Page 126 - Mercy MOR All Regions_FinalwVideo

Key Performance Indicators Metric $2,109 Toledo (193) 0.6% % Variance 16.9% $2,000
Budget
Variance
Prior
Actual
Supply Expense
$14,385,799
$13,266,587
($583,842)
-4.2%
$13,801,957
$79,649,291
$540,008
0.6%
Net Patient Revenue
$86,374,699
$86,914,707
3.8%
16.0%
16.7%
16.6%
Supply Expense % Net Patient Revenue
$96
$2,205
4.4%
Supply Expense per EIPA
3,376
2,888
488
3,335
Total Admissions
14,751
13,527
Total Patient Days
13,720
-1.4%

6,821
6,634
6,258
Total EIPAs
563

9.0%

IP Surgeries
OP Surgeries
-12.0%

2,047
2,156
2,451
2,629

2,952
-12.9%
2,572

Total Surgeries
195
(13)
178

Outpatient Cath Lab Procedures 416 501 (295) (380) (85) -17.0% 582
-6.7%
182
Site Performance Summary
Overall supply expense was unfavorable to budget by $608K. Admissions were up 16.1%, Patient days down 1.4% & ED visits up 2.4%.
Surgery volume mixed, IP/OP were up 27.6% & down 13.4%.
Primary drivers of varainces were Non CRM implants ($708K), Drugs ($121K), Lab ($187K) & IV/IV sets ($107K).
Non CRM expense driven by growth in Spine at St Anne's ($198K); Rx driven by Blood, Coagulant & Thrombosis drugs at St Charles & St
Vincent's ($164.4K); Orthopedic joints increased in Rural facilites and remained flat in Metro but volume higher than budgeted ($136K);
Implant Other due to increase in penile implants at St Vincent's ($30K), re-class of product to Endomechanical ($39K) and three new
Surgeons, Drs Hacker, Momoh & Oriwo ($82.4K).
Lab experienced a spike in flu supplies such as flu test kits ($90.2K), D-dimer test kits ($15.8K) and out of period spend ($23.5K).
Increased admissions & ED volumes contribute to IV/IV Set expense which lead to higher than normal usage of IV related products (i.e.
solutions, IV start kits, IV tubing) - $98K
Overall flu related expense increase for Region was $170K. Key Challenges
Toledo Leader's Summary Med/Surg Maintain spend below budget in light of increased patient & surgery volumes
Maintaining medical surgical expense as a percentage of revenue ratio in an environment of
declining and increasing volume
Increased spend for new surgeons
Maintain revenue growth as retail pharmacy expenses increase.
Rx
Address procedures that produce negative contribution margins
New ortho surgeon at St Charles
Implants
Managing peaks and valleys associated with Davinci instrument expense
Other Expenses Unbudgeted Other Non Medical expenses
Increased expense related to flu supplies
Actions Taken/Planned:
Meeting monthly with Surgery to review epenses and procedures generating negative
Implants
contriubtion margins.
Overall impact from flu related Reviewing product inventory positions and open orders daily
Ortho Met with surgery to understand finaicial impact of Navio robot procedures
Surgery Establishing a physician onboarding process.